HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmopolitan signs Tom Tailor

This article was originally published in The Rose Sheet

Executive Summary

Licensing agreement between Cosmopolitan Cosmetics and apparel brand Tom Tailor will yield men's fragrance line by fall 2004, Wella's cosmetics and fragrances division announces March 10. Development of fragrances and body care products marks international expansion opportunity for the Hamburg-based Tom Tailor fashion label, company states. Tom Tailor fashion generated sales of $378.3 mil. (€1=$1.08) in 2002, according to Wella. Licensing agreement is Wella's second partnership with a German apparel company in four months. Wella announced similar partnership with fashion designer Gerry Weber in 2002 (1"The Rose Sheet" Dec. 16, 2002, In Brief)...

You may also be interested in...



Cosmopolitan/Gerry Weber partnership

Licensing agreement between Cosmopolitan Cosmetics and women's apparel firm Gerry Weber will yield first women's fragrance in summer 2004, Wella division announces. Cosmopolitan Cosmetics said it signed a long-term licensing agreement to market Gerry Weber fragrances and body care products Dec. 9. Fragrance will be distributed internationally, Wella says, noting Gerry Weber's five fashion brands are distributed in 56 countries. German apparel and accessories firm, founded in 1986, generated approximately €400 mil. in sales in 2001 financial year...

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.

UsernamePublicRestriction

Register

RS011042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel